India’s pharmaceutical ecosystem is entering a transformative phase in 2026, driven by expanding healthcare needs, manufacturing advancements, technological innovation, and the country’s growing prominence in global pharmaceutical supply chains.
As India continues to strengthen its position as the “pharmacy of the world,” pharmaceutical manufacturers and product solution providers are emerging as vital contributors to a healthcare landscape that increasingly demands quality, affordability, accessibility, and... >>More
Jennifer Li, SVP & Head of Sales - APAC, Medidata
Dr Rajiv Chhibber, Joint Forum Coordinator, Association, Indian Medical Device Industry (AiMeD)
Dr Kuber Jagdale, President - API Business Unit, Emcure Pharmaceutical Business Formation
Dr Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis